Hengrui Therapeutics

Hengrui Therapeutics is a biopharmaceutical company dedicated to the development and commercialization of innovative cancer therapies. The company's drug pipeline includes multiple clinical-stage oncology and immuno-oncology assets. As part of its corporate mission, HTI is firmly committed to fighting cancer and other serious diseases worldwide.